Please Wait

Applying Filters...

Chinese FDA-registered generic facilities gain steam, India maintains lead with 396 facilities

Data Compilation
#PharmaFlow

Pipeline Prospector Nov 2024: Trump’s HHS pick drags down jab makers’ stocks; Novartis, Merck, Roche ink billion-dollar deals

Stock Recap
#PipelineProspector

Flunixin Meglumine

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

16 API Suppliers, 1 USDMF, 9 CEP/COS, 7 NDC API, 9 VMF, 7 Listed Suppliers, $ API Reference Price

INTERMEDIATES

1 Intermediates Suppliers

1 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

8 FDF Dossiers, 6 Canada, 2 Listed Dossiers

RELATED EXCIPIENT COMPANIES

3 SPI Pharma, 2 Seqens, 1 Faran Shimi Pharmaceutical, 1 Boai NKY Pharmaceuticals Ltd, 6 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 5 Actylis, 1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 11 BASF, 2 Finar, 1 Gangwal Chemicals, 2 Ingredion Pharma Solutions, 1 Kerry, 2 Nomisma Healthcare, 1 Pluviaendo, 6 Roquette, 1 Seppic, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

15 Fillers, Diluents & Binders, 12 Topical, 9 Direct Compression, 8 Solubilizers, 7 Thickeners and Stabilizers, 7 Controlled & Modified Release, 6 Parenteral, 6 Co-Processed Excipients, 4 Disintegrants & Superdisintegrants, 4 Film Formers & Plasticizers, 3 Taste Masking, 3 Chewable & Orodispersible Aids, 2 Granulation, 2 Coating Systems & Additives, 1 Emulsifying Agents